Alcaloidi oppiacei

Applications Present in opium from 0.7% to 2.5%, depending on the source. Weak narcotic analgesic, perhaps due to conversion to morphine, with minimal hypnotic properties; potent antitussive.Controlled substance (opiate).
References Eddy, S., et al.: J. Pharmacol. Exp. Ther., 67, 127 (1939), Muhtadi, F.J., et al.: Anal. Profiles Drug Subs., 10, 93 (1981),

Applications Present in opium from 0.7% to 2.5%, depending on the source. Weak narcotic analgesic, perhaps due to conversion to morphine, with minimal hypnotic properties; potent antitussive.Controlled substance (opiate).This compound is a contaminant of emerging concern (CECs).
References Eddy, S., et al.: J. Pharmacol. Exp. Ther., 67, 127 (1939), Muhtadi, F.J., et al.: Anal. Profiles Drug Subs., 10, 93 (1981).

Applications N-(4-Fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide is an impurity of Furanylfentanyl (F864085), which is an opiod analgesic agent and an analog of Fentanyl (F275000). In addition, N-(4-Fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4-piperidinyl]-propanamide may be a useful compound for developing fentanyl-conjugated vaccines by utilizing a protein–drug conjugate that generates an in vivo immunoantagonist, which can minimize the concentration of a specific drug at the sites of action.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Bremer, P. T., et al.: Angew. Chem. Int. Ed. 55, 3772 (2016); Zernig, G., et al.: Life Sci., 57, 2113 (1995), Bot, G., et al.: J. Pharmacol. Exper. Therap., 285, 1207 (1998)

Applications Analgesic (narcotic); antitussive. Mydriatic.Controlled substance.
References Ertl, P., et al.: J. Med. Chem., 43, 3714 (2000), Jones, A., et al.: Toxicol. Rev., 25, 15 (2006), Schwilke, E., et al.: J. Forensic Sci., 51, 1191 (2006),

Applications An impurity in the synthesis of morphine, with pharmaceutical properties similar to that of morphine.
References Farsam, H., et al.: Pharm. Res., 7, 1205 (1990);

Applications The α-Prodine isomer (P755300). Analgesic (narcotic). Controlled substance (opiates).
References Gruber, G.M., et al.: J. Pharmacol. Exp. Ther., 99, 312 (1950), Abdel-Monem, M.M., et al.: J. Med. Chem., 15, 494 (1972),

Applications An intermediate of Isomethadone (Isoamidone).
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Unterhalt, B., et al.: Pharmaceutica, 68, 229 (2000),

Applications 15-Keto Bimatoprost is an impurity of Bimatoprost (B386800). Bimatoprost impurity III.
References Stjernschantz, J., et al.: Drugs Fut., 17, 691 (1992), Resul, B., et al.: J. Med. Chem., 36, 243 (1993),

Applications A lactone of meconinic acid, extracted from opium. Meconin is a marker for illicit opiate use.
References Pavlic, M., et al.: Anal. Bioanal. Chem., 386, 69 (2006), Morley, S., et al.: J. Anal. Toxicol., 31, 105 (2007), Ashour, A., et al.: Drug Test. Anal., 1, 327 (2009);

Applications Levomethorphan is the enantiomer of Dextromethorphan (D299455), an antitussive medicine, a narcotic. Controlled substance.
References Hafliger, et al.: Helv. Chim. Acta, 39, 2053 (1956), Cox, B.M., et al.: Br. J. Pharmacol. Chemother., 27, 81 (1966), Hou, Chia-Hui; Tzeng, J., et al.: Eur. J. Pharmacol., 544, 10 (2006),

Applications An analgesic derivative of the synthetic μ-opiate agonist (R)-Methadone (M225880) and a precursor of β-Acetylmethadol. It does not evoke heroin-like discriminative stimulus effects unlike other methadone derivatives. It has inhibitory effect on 5-Hydroxytryptamine (H974990) uptake.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Newman, J.L. et al.: Psychopharmacol., 164, 108 (2002); Brase, D.A. et al.: Biochem. Pharmacol., 25, 1684 (1976); Casy, A.F. et al.: J. Med. Chem., 11, 601 (1968);

Applications Labelled specific opioid antagonist. Narcotic antagonist.
References Jasinski, D.R., et al.: J. Pharmacol. Exp. Ther., 157, 420 (1967), McNicholas, L.F., et al.: Drugs, 27, 81 (1984), Hasson, M.M.A., et al.: Anal. Profiles Drug Subs., 14, 453 (1985), Stowe, C., et al.: Ann. Pharmacother., 27, 447 (1993),

Impurity Naloxone Impurity G
Applications Naloxone 3-Methyl Ether is an Intermediate for the synthesis of Labelled Naloxone (N285000), a specific opioid antagonist and narcotic antagonist.
References Jasinski, D. R., et al.: J. Pharmacol. Exp. Ther., 157, 420 (1967), McNicholas, L. F., et al.: Drugs, 27, 81 (1984), Hasson, M. M. A., et al.: Anal. Profiles Drug Subs., 14, 453 (1985), Stowe, C., et al.: Ann. Pharmacother., 27, 447 (1993)

Applications Nonselective opioid receptor antagonist; congener of Naloxone.
References Maickel, R.P., et al.: Ann. N.Y. Acad. Sci., 281, 321 (1976), Gritz, E.R., et al.: Clin. Pharmacol. Ther., 19, 773 (1976), Gonzales, J.P., et al.: Drugs, 35, 192 (1988), Berg, B.J., et al.: Drug Saf., 15, 274 (1996),

Applications Tetrahydrofuran Fentanyl Hydrochloride is a derivative compound of Acetyl Fentanyl (A175000). Acetyl Fentanyl is a new synthetic opioid and a metabolite of fentanyl.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Watanbe, S., et al.: AAPS J., et al.: 1102-1122 (2017); Wang, B., et al.: J. Anal. Toxicol., 38, 672-675 (2014); Katselou, M., et al.: Forensic Toxicol., 34, 201-212 (2016)

Applications Controllled substance (opiate).
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Csokan, Z., et al.: Anal. Chem., 124, 344 (1942), Barber, R., et al.: J. Med.Chem., 18, 1074 (1975), Bird, D., et al.: Plant Cell, 15, 2626 (2003), Park, S., et al.: Plant Mol. Biol., 51, 153 (2003),